Pacific Biosciences Of California (PACB) Non-Current Deffered Revenue (2011 - 2026)
Pacific Biosciences Of California's quarterly Non-Current Deffered Revenue came in at $3.6 million in Q1 2026, down 39.3% year-on-year from $5.9 million in Q1 2025, and down 9.54% quarter-over-quarter from $3.9 million in Q4 2025.
Pacific Biosciences Of California has reported Non-Current Deffered Revenue for 16 years, with the latest figure at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deffered Revenue fell 39.3% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 39.3% YoY), and the FY2025 full-year result was $3.9 million, down 33.41% from the prior year.
- Non-Current Deffered Revenue for Q1 2026 stood at $3.6 million, down from $3.9 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $25.2 million in Q1 2022, with the low at $1.8 million in Q3 2022.
- Average Non-Current Deffered Revenue over 5 years is $5.6 million, with a median of $5.1 million recorded in 2023.
- Peak annual rise in Non-Current Deffered Revenue reached 342.91% in 2022, while the deepest fall reached 92.84% in 2022.
- Tracing PACB's Non-Current Deffered Revenue over 5 years: stood at $1.8 million in 2022, then surged by 208.25% to $5.5 million in 2023, then advanced by 6.69% to $5.9 million in 2024, then plunged by 33.41% to $3.9 million in 2025, then dropped by 9.54% to $3.6 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $3.6 million (Q1 2026), $3.9 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 3.93 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 5.71 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 5.10 Mn |
| Jun 30, 2023 | 4.99 Mn |
| Mar 31, 2023 | 1.85 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.83 Mn |
| Mar 31, 2022 | 25.25 Mn |
| Dec 31, 2021 | 25.05 Mn |
| Jun 30, 2021 | 10.20 Mn |
| Mar 31, 2021 | 5.70 Mn |
| Dec 31, 2020 | 1.57 Mn |
| Sep 30, 2020 | 1.76 Mn |
| Jun 30, 2020 | 1.53 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 1.95 Mn |
| Sep 30, 2019 | 1.44 Mn |
| Jun 30, 2019 | 1.45 Mn |
| Mar 31, 2019 | 769,000.00 |
| Dec 31, 2018 | 890,000.00 |
| Sep 30, 2018 | 13.95 Mn |
| Jun 30, 2018 | 14.11 Mn |
| Mar 31, 2018 | 14.29 Mn |
| Dec 31, 2017 | 1.08 Mn |
| Sep 30, 2017 | 1.07 Mn |
| Jun 30, 2017 | 1.30 Mn |
| Mar 31, 2017 | 14.15 Mn |
| Dec 31, 2016 | 19,000.00 |
| Sep 30, 2016 | 1.02 Mn |
| Jun 30, 2016 | 952,000.00 |
| Mar 31, 2016 | 882,000.00 |
| Dec 31, 2015 | 1.14 Mn |
| Sep 30, 2015 | 1.25 Mn |
| Jun 30, 2015 | 1.32 Mn |
| Mar 31, 2015 | 1.61 Mn |
| Dec 31, 2014 | 1.13 Mn |
| Sep 30, 2014 | 918,000.00 |
| Jun 30, 2014 | 872,000.00 |
| Mar 31, 2014 | 842,000.00 |
| Dec 31, 2013 | 518,000.00 |
| Sep 30, 2013 | 28.88 Mn |
| Jun 30, 2013 | 734,000.00 |
| Mar 31, 2013 | 794,000.00 |
| Dec 31, 2012 | 800,000.00 |
| Sep 30, 2012 | 1.00 Mn |
| Jun 30, 2012 | 1.48 Mn |
| Mar 31, 2012 | 1.44 Mn |
| Dec 31, 2011 | 1.62 Mn |